🇺🇸 FDA
Patent

US 9445870

Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye

granted A61PA61P27/02A61P31/04

Quick answer

US patent 9445870 (Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye) held by Montefiore Medical Center expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Montefiore Medical Center
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P27/02, A61P31/04